Prognosis in UC After First Biological

Sponsor
Tampere University Hospital
Study ID
NCT05530122
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
16 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

To study the long-term clinical outcome of patients with ulcerative colitis treated with first trial of biological therapy.

Key Dates

Start date
Jan 31, 2009
Status verified
Sep 2022
Primary completion
Jan 31, 2020
Completion
Aug 26, 2022

Study Design

Enrollment
192 participants (actual)

Primary Outcome Measure

Response to treatment [ Time Frame: within 5 years ]

Related Studies